BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28895709)

  • 1. Recombinant tissue plasminogen activator treatment for intracardiac vegetation in a very low birth weight infant.
    Ozdemir AA
    Arch Argent Pediatr; 2017 Oct; 115(5):e307-e310. PubMed ID: 28895709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of neonatal fungal infective endocarditis with recombinant tissue plasminogen: activator in a low birth weight infant case report and review of the literature.
    Babayigit A; Cebeci B; Buyukkale G; Semerci SY; Bornaun H; Oztarhan K; Gokce M; Cetinkaya M
    Mycoses; 2015 Oct; 58(10):578-81. PubMed ID: 26214750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of an infant infected with refractory C. parapsilosis with caspofungin.
    Ozkaya-Parlakay A; Tezer H; Kazmacan T; Gulhan B; Unal S
    J Trop Pediatr; 2014 Aug; 60(4):329-30. PubMed ID: 24567311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans.
    Victorio GB; Bourdon LMB; Benavides LG; Huerta-Olvera SG; Plascencia A; Villanueva J; Martinez-Lopez E; Hernández-Cañaveral II
    Mem Inst Oswaldo Cruz; 2017 May; 112(5):370-375. PubMed ID: 28443984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated candidemia refractory to caspofungin therapy in an infant with extremely low birth weight.
    Li MJ; Hsueh PR; Lu CY; Chou HC; Lee PI; Chang LY; Huang LM
    J Formos Med Assoc; 2012 Jan; 111(1):46-50. PubMed ID: 22333013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida endocarditis: role of new antifungal agents.
    Talarmin JP; Boutoille D; Tattevin P; Abgueguen P; Ansart S; Roblot F; Raffi F
    Mycoses; 2009 Jan; 52(1):60-6. PubMed ID: 18498304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
    del Castillo M; Wainsztein N; Klein F; Manganello S; Orellana N
    Medicina (B Aires); 2004; 64(2):152-4. PubMed ID: 15628305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocarditis caused by Candida dubliniensis.
    Garcia J; Soch K; Matthew E; Surani S; Horseman MA
    Am J Med Sci; 2013 Sep; 346(3):237-9. PubMed ID: 23974269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient--case report and review of literature.
    Bacak V; Biocina B; Starcevic B; Gertler S; Begovac J
    J Infect; 2006 Jul; 53(1):e11-4. PubMed ID: 16274746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspofungin therapy of neonates with invasive candidiasis.
    Odio CM; Araya R; Pinto LE; Castro CE; Vasquez S; Alfaro B; Sàenz A; Herrera ML; Walsh TJ
    Pediatr Infect Dis J; 2004 Dec; 23(12):1093-7. PubMed ID: 15626944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspofungin: a new therapeutic option for fungal endocarditis.
    Nevado J; De Alarcón A; Hernández A
    Clin Microbiol Infect; 2005 Mar; 11(3):248. PubMed ID: 15715728
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
    Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
    Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of Candida albicans endocarditis vegetations with recombinant tissue plasminogen activator in an extremely low birth weight preterm infant.
    Aydemir C; Erdeve O; Oguz SS; Altug N; Dilmen U
    Mycoses; 2011 Sep; 54(5):e590-2. PubMed ID: 20492524
    [No Abstract]   [Full Text] [Related]  

  • 14. [Micafungin for the treatment of neonatal invasive candidiasis].
    Infante-López ME; Rojo-Conejo P
    Rev Iberoam Micol; 2009 Mar; 26(1):56-61. PubMed ID: 19463278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement.
    Rajendram R; Alp NJ; Mitchell AR; Bowler IC; Forfar JC
    Clin Infect Dis; 2005 May; 40(9):e72-4. PubMed ID: 15825018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal liver abscesses due to Candida infection effectively treated with caspofungin.
    Filippi L; Poggi C; Gozzini E; Meleleo R; Mirabile L; Fiorini P
    Acta Paediatr; 2009 May; 98(5):906-9. PubMed ID: 19187395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful caspofungin treatment of multidrug resistant Candida parapsilosis septicaemia in an extremely low birth weight neonate.
    Yalaz M; Akisu M; Hilmioglu S; Calkavur S; Cakmak B; Kultursay N
    Mycoses; 2006 May; 49(3):242-5. PubMed ID: 16681818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echinocandin use in the neonatal intensive care unit.
    Caudle KE; Inger AG; Butler DR; Rogers PD
    Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment.
    Jiménez-Expósito MJ; Torres G; Baraldés A; Benito N; Marco F; Paré JC; Moreno A; Claramonte X; Mestres CA; Almela M; García de la María C; Pérez N; Schell WA; Corey GR; Perfect J; Jiménez de Anta MT; Gatell JM; Miró JM
    Clin Infect Dis; 2004 Oct; 39(7):e70-3. PubMed ID: 15472836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of micafungin in treating four premature infants with candidiasis.
    Kawaguchi C; Arai I; Yasuhara H; Sano R; Nishikubo T; Takahashi Y
    Pediatr Int; 2009 Apr; 51(2):220-4. PubMed ID: 19405920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.